Omega Plastics Group achieves ISO 14001 status
14 Jun 2023
Omega Plastics Group, an integrated plastic injection moulding group, has achieved ISO 14001 certification. ISO 14001 is an international standard that sets out the requirements for an environmental management system (EMS).
The certification is a process that requires companies to demonstrate their commitment to environmental management. It includes an assessment of a company’s EMS practices, policies, and procedures.
During the process, Omega Plastics Group was able to demonstrate its focus on reducing waste and emissions, conserving natural resources, and promoting sustainable practices. This included the use of recycled materials, investing in energy-efficient manufacturing equipment and LED lighting, monitoring, and reducing energy usage, taking steps to reduce water usage, and managing waste responsibly.
“We are delighted to achieve ISO 14001 certification” said Craig Swinhoe, chief executive officer at Omega Plastics Group. “A key part of our vision is to be a sustainable manufacturer. Obtaining ISO 14001 demonstrates the importance to us of environmental sustainability. We are committed to reducing our environmental impact, waste and costs and helping our customers do the same. I am proud of our team’s ongoing efforts to make a positive impact on the environment.”
Julian Jamieson, group operations director, further explained “ISO 14001 reduces our environmental impact by helping us to identify and manage our environmental risks and opportunities. It allows us to improve our environmental performance by setting measurable environmental objectives and targets, and by monitoring and reporting on their progress.
“ISO 14001 and the systematic approach to environmental management will help us to comply with environmental regulations. It also means that we are well positioned to meet the changing environmental needs of our customers.”
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.